Gelonghui, December 23丨Shanghai Sanyou Medical Co., Ltd (688085.SH) announced that the company plans to acquire a total of 37.1077% equity in Beijing Shuimu Tianpeng Medical Technology Co., Ltd. (hereinafter referred to as "Shuimu Tianpeng") held by Cao Qun and Xu Nong through the issuance of shares and cash payment, and 98.9986% limited partnership capital contribution shares in Shanghai Huanzhan Enterprise Management Partnership (Limited Partnership) (hereinafter referred to as "Shanghai Huanzhan") held by 11 counterparties including Zhan Songtao, and to acquire 1.0014% general partner capital contribution shares of Shanghai Huanzhan held by Zhangjiagang Tianpeng Investment Management Co., Ltd. through its subsidiary Tuoteng (Suzhou) Medical Technology Co., Ltd. in cash, and to raise supporting funds through issuing shares (hereinafter referred to as "this transaction").
According to the announcement from the Mergers and Acquisitions Review Committee of the Shanghai Stock Exchange, the 7th review meeting of the Mergers and Acquisitions Review Committee of the Shanghai Stock Exchange will be held on December 30, 2024, to review the company's application for this transaction.
